Search Results for: Merck Set to Lead Licensing
Articles
Merck Set to Lead Licensing Deals in 2018 February 9, 2018
The pharmaceutical industry is highly volatile, with promising lead candidates making or breaking a company’s year. Companies’ financial success is...Aduro Announces Development Milestone Achieved Under Merck Collaboration March 16, 2018
Aduro Biotech, Inc. recently announced that the company earned a $3-million development milestone payment under its worldwide licensing agreement with Merck…
Aduro Announces Development Milestone Achieved Under Merck Collaboration March 5, 2018
Aduro Biotech, Inc. recently announced that the company earned a $3-million development milestone payment under its worldwide licensing agreement with...Viking Signs Broad Licensing Deal With Ligand May 27, 2014
Viking Therapeutics, Inc. recently announced it has obtained an exclusive worldwide license to five novel therapeutic programs from Ligand Pharmaceuticals...Merck Plans Radical Overhaul of R&D Unit January 7, 2014
Merck & Co. Inc. is working on a plan to radically reshape its once-storied R&D unit that would create international...MARKET BRIEF - Financial Performance Benchmarking & Competitive Landscape Assessment of Leading CROs November 18, 2013
Adam M. Dion, MS, summarizes GlobalData’s recent CRO Benchmark Report and believes the dynamics of pharmaceutical outsourcing and location decisions in emerging markets are changing. Cost reduction is being augmented and will gradually be eclipsed by footprint growth as a major factor shaping decisions, and CROs are realizing that the ability to be on the ground closer to their customers is a key building block to establishing sustainable, long-term relationships with clients.
Ovid Therapeutics & Ligand Pharmaceuticals Enter $30-Million Agreement October 18, 2023
Ovid Therapeutics Inc. and Ligand Pharmaceuticals Incorporated recently announced Ligand has acquired a 13% portion of the royalties and milestones owed to Ovid related to the potential approval and commercialization of….
ONCOLOGY DIAGNOSTICS - Advancements Paving the Way for More Tailored Drugs November 20, 2017
Divyaa Ravishankar, MS, says pharmaceutical companies have been subjected to a wide variety of external forces compelling them to get innovative about development of new platforms, liaise with new partners, leverage big data toward precision and predictive diagnosis, and identify new markers.
Ligand Signs $4.5-Million Agreement With Omthera Pharmaceuticals May 19, 2014
Ligand Pharmaceuticals Incorporated recently announced it has entered into a licensing agreement and research collaboration with Omthera Pharmaceuticals, Inc., a...Akorn Acquires Three Branded Ophthalmic Products November 19, 2013
Akorn, Inc. recently announced it has acquired from Merck, the US rights to three branded ophthalmic products, including those product...1/23/2012 January 21, 2013
Amgen Invests $200 Million in Monoclonal Antibodies Amgen recently announced plans to build a new manufacturing facility in the Tuas...10/24/2012 October 21, 2012
Avantor & Rubicon to Collaborate on Next-Generation Functional Excipients Avantor Performance Materials recently announced it has signed a collaboration...6/27/2012 June 25, 2012
Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted...6/20/2012 June 18, 2012
Astex Earns $5.4-Million Milestone Astex Pharmaceuticals, Inc. recently announced that Janssen Pharmaceutica NV has received clearance to commence a Phase...5/16/2012 May 14, 2012
Mucosis Announces Positive Data for Mimopath Platform Mucosis B.V. recently announced Phase I clinical data providing proof-of-concept that Mimopath-based mucosal...4/3/2012 March 29, 2012
Aptar Pharma's Device Delivers INSYS Therapeutics' Drug Aptar Pharma recently announced INSYS Therapeutics' SUBSYS, which uses an Aptar Pharma Sublingual...2/7/2012 February 5, 2012
Foster Analytical Services Speed Time to Market for Drug Delivery Formulations Foster Delivery Science, a business unit for Foster Corporation,...12/13/2011 December 11, 2011
Abbott Laboratories Spends $400 Million on Development Deal Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide...11/22/2011 November 20, 2011
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life...9/27/2011 September 25, 2011
Thermo Fisher Scientific Introduces New Imaging ATR Accessory Thermo Fisher Scientific Inc., a world leader in serving science, recently announced...
